All posts in Stem Cell Research

NeoStem, Inc. (AMEX: NBS, StockTwits: $NBS) announced that its majority-owned Suzhou Erye Pharmaceutical Company Ltd. subsidiary recently received two awards at the Chempharm Brand Summit 2011 held in

Bioheart, Inc. (OTCBB: BHRT, Twitter: $BHRT) has released a corporate Power Point presentation to further educate investors about the Bioheart technologies as a new therapy for heart disease. 

Bioheart, Inc. (OTCBB:BHRT) is a biotechnology company focused 100 percent on cell therapy products for the heart. Specialized as such and led by a team of industry

Medistem (MEDS.PK) Shares up Big on Stem Cell News Shares of Medistem, Inc. are soaring today after the Company released news of a peer-reviewed publication on its data

It was only eight days ago that Advanced Cell Technology (“ACT”) announced that they have been granted U.S. Food and Drug Administration approval to proceed with human studies

Earlier this month, a historic moment happened; human embryonic stem cells were used to treat a patient in Atlanta. Geron Corporation received the first United States Food

With Geron Corp (GERN) now receiving clearance from the U.S. Food and Drug Administration to proceed with human trials of stem cell research on spinal injury patients and

A recent poll conducted by Harris Interactive/Healthday spanning a wide spectrum of demographic groups, including Republicans, Catholics and born-again Christians, showed that an overwhelming amount of Americans support

Advance Cell Technology, Inc. (“ACT”), an industry leader in regenerative medicine arena, recently announced that it has safely and successfully completed Phase I human trials of its myoblast